Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

When and in Whom to Stop Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis

NCT01287715 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT01287715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01287715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
When and in Whom to Stop Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis
Lead sponsor
Erasmus Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2011
Completion date
September 30, 2013
Enrollment
50 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

juvenile idiopathic arthritis